Likewise, inhibition of haem biosynthesis using hemin, an approved drug used for acute porphyria, reduced colony formation of FH-deficient cells, altogether indicating that cells lacking FH critically depend on this unusual pathway and that haem biosynthesis and degradation pathways may be attractive targets in the treatment of FHdRCC (24, 26). This evidence concerns the gene FH and hepatic porphyria.